Section 10021 - Office-Based Narcotic Treatment Network (Obntn)(a) An OBNTN may lawfully operate if: (1) The Department approves the primary NTP's supplemental written protocol as described in subsection (b); and(2) The primary NTP has approval from SAMHSA, if required.(b) The primary NTP program sponsor shall submit an Initial Application Coversheet form DHCS 5014 (04/16) and supplemental written protocol to the Department to serve as an application to add an OBNTN to the primary NTP license. The supplemental written protocol shall include all of the following information and designated forms: (1) A description of the geographical surrounding areas to be served, as required by the Facility and Geographical Area form DHCS 5025 (04/16);(2) The population of the area to be served, as required by the Facility and Geographical Area form DHCS 5025 (04/16);(3) Each staff member's resume and Staff Information form DHCS 5026 (04/16);(4) A facility address, including the geographic relationship of the OBNTN to the primary NTP, as required by the Facility and Geographical Area form DHCS 5025 (04/16);(5) The days and hours of operation, as required by the Facility and Geographical Area form DHCS 5025 (04/16);(6) The type of services to be provided and the hours of use of the facility, if the facility is also used for purposes other than an OBNTN, as required by the Facility and Geographical Area form DHCS 5025 (04/16);(7) A facility description including a diagram showing dimensions of the facility housing the OBNTN and an accompanying narrative that describes patient flow. The diagram and narrative shall specify waiting areas, office space, record storage area, and parking or transportation access, as required by the Facility and Geographical Area form DHCS 5025 (04/16);(8) The approximate number of patients to be served and a description of how every patient that is assigned to the OBNTN will participate in the regular treatment provided by the primary NTP, as required by the Facility and Geographical Area form DHCS 5025 (04/16); and(9) The written policies and procedures to be followed in the event of an emergency or disaster.(c) In addition to the supplemental written protocol, the primary NTP shall submit to the Department an Affiliated and Associated Acknowledgement form DHCS 5134 (04/16).(d) The Department shall notify the primary NTP, in writing, within 60 days of receipt of the Initial Application Coversheet form DHCS 5014 (04/16), supplemental written protocol, and the Affiliated and Associated Acknowledgement form DHCS 5134 (04/16), whether the documents are:(1) Complete, including all required documents specified in subsections (b) and (c), and accepted for review; or(2) Incomplete, and the Department shall specify the missing or incomplete information or documentation. The primary NTP shall have 60 days from the date of the notification to provide the missing information or documentation. The Department shall terminate review of the application if the primary NTP does not provide the required information or documentation within 60 days. Upon termination of review, the incomplete application shall be returned to the primary NTP. A primary NTP may reapply by submitting a new application to the Department. Termination of review of the application shall not constitute a licensing action.(e) The proposed OBNTN shall be subject to a site inspection by the Department prior to approval of the supplemental written protocol.(f) The Department shall either approve or deny, in writing, a complete application for approval of an OBNTN within 60 days after the application is accepted for review.(g) The primary NTP shall notify the Department, in writing, at least 30 days prior to the closure of an OBNTN. In the event that an OBNTN ceases to provide services, the primary NTP shall be responsible for providing those services.(h) The licensed patient capacity of the primary NTP and any of its medication unit(s) and/or OBNTN(s) shall not exceed the patient capacity set forth on the primary NTP license.(i) An OBNTN shall be subject to the same inspection and monitoring by the Department as a narcotic treatment program, to ensure that operations are in accordance with the applicable laws and regulations.(j) The primary NTP shall be responsible for submission and implementation of all required corrective action plans for any of its OBNTNs. The license of the primary NTP shall be subject to licensing action, as described in Section 10057, for any violation by its OBNTNs of these regulations or provisions under Article 1, Chapter 10, Part 2, Division 10.5 of the Health and Safety Code.(k) An OBNTN shall post the primary NTP license under which it is operating that identifies all addresses of all facilities providing treatment services in a conspicuous place visible within the facility.(l) The primary NTP shall be responsible for ensuring that patients have access to all other treatment services not provided at the OBNTN.Cal. Code Regs. Tit. 9, § 10021
1. New section filed 5-7-2020; operative 7-1-2020 (Register 2020, No. 19). Note: Authority cited: Sections 11750, 11755, 11835, 11839.3, 11839.6 and 11839.20, Health and Safety Code. Reference: Section 11839.3, Health and Safety Code.
1. New section filed 5-7-2020; operative 7/1/2020 (Register 2020, No. 19).